Compare LOCO & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOCO | ANGO |
|---|---|---|
| Founded | 1980 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.5M | 420.2M |
| IPO Year | 2014 | 2004 |
| Metric | LOCO | ANGO |
|---|---|---|
| Price | $15.45 | $15.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $14.17 | ★ $18.00 |
| AVG Volume (30 Days) | 242.2K | ★ 340.9K |
| Earning Date | 05-07-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.65 | N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $401,701,000.00 | $291,010,000.00 |
| Revenue This Year | $3.60 | $9.51 |
| Revenue Next Year | $3.98 | $4.96 |
| P/E Ratio | $21.93 | ★ N/A |
| Revenue Growth | 5.68 | ★ 10.17 |
| 52 Week Low | $8.99 | $9.39 |
| 52 Week High | $17.40 | $16.29 |
| Indicator | LOCO | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.14 | 58.79 |
| Support Level | $15.10 | $10.56 |
| Resistance Level | $15.75 | $16.20 |
| Average True Range (ATR) | 0.39 | 0.41 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 45.11 | 54.90 |
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.